ETF Managers Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $2.08M | Sell |
|
|||||
|
2022
Q4 | $2.64M | Sell |
|
|||||
|
2022
Q3 | $2.25M | Sell |
|
|||||
|
2022
Q2 | $5.12M | Buy |
|
|||||
|
2022
Q1 | $2.79M | Sell |
|
|||||
|
2021
Q4 | $3.81M | Sell |
|
|||||
|
2021
Q3 | $4.56M | Buy |
|
|||||
|
2021
Q2 | $3.13M | Sell |
|
|||||
|
2021
Q1 | $3.62M | Buy |
|
|||||
|
2020
Q4 | $2.58M | Buy |
|
|||||
|
2020
Q3 | $2.66M | Buy |
|
|||||
|
2020
Q2 | $1.53M | Buy |
|
|||||
|
2020
Q1 | $320K | Buy |
|
|||||
|
2019
Q4 | $303K | Buy |
|
|||||
|
2019
Q3 | $165K | Sell |
|
|||||
|
2019
Q2 | $150K | Buy |
|
|||||
|
2019
Q1 | $112K | Buy |
|
|||||
|
2018
Q4 | $79K | Buy |
|
|||||
|
2018
Q3 | $82K | Buy |
|
|||||
|
2018
Q2 | $66 | Sell |
|
|||||
|
2018
Q1 | $139K | Buy |
|
|||||
|
2017
Q4 | $158K | Buy |
|
|||||
|
2017
Q3 | $121K | Buy |
|
|||||
|
2017
Q2 | $75K | Buy |
|
|||||
|
2016
Q1 | $23K | Buy |
|